MGMT is frequently inactivated in pancreatic NET-G2 and is associated with the therapeutic activity of STZ-based regimens
Abstract O6-methylguanine-DNA methyltransferase (MGMT) has been linked with alkylating agent resistance and tumor growth suppression. However, its role remains undetermined in pancreatic neuroendocrine tumors (Pan-NET). The MGMT expression was examined by immunohistochemistry in 142 patients to eval...
Main Authors: | Kohei Yagi, Hiroaki Ono, Atsushi Kudo, Yuko Kinowaki, Daisuke Asano, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Shinji Tanaka, Minoru Tanabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-34666-y |
Similar Items
-
Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinoma
by: Kohei Yagi, et al.
Published: (2023-06-01) -
Surgery after sunitinib administration to improve survival of patients with advanced pancreatic neuroendocrine neoplasms
by: Yoshiki Murase, et al.
Published: (2021-09-01) -
Successful conversion surgery of distal pancreatectomy with celiac axis resection (DP-CAR) with double arterial reconstruction using saphenous vein grafting for locally advanced pancreatic cancer: a case report
by: Yoshiki Murase, et al.
Published: (2020-12-01) -
Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.
by: Toshitaka Sugawara, et al.
Published: (2021-01-01) -
Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells.
by: Tomotaka Kato, et al.
Published: (2021-01-01)